nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP1A2—Pentoxifylline—systemic scleroderma	0.11	0.226	CbGbCtD
Cilostazol—CYP1A2—Leflunomide—systemic scleroderma	0.105	0.215	CbGbCtD
Cilostazol—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0874	0.179	CbGbCtD
Cilostazol—CYP2D6—Captopril—systemic scleroderma	0.0681	0.139	CbGbCtD
Cilostazol—CYP2C19—Prednisone—systemic scleroderma	0.0564	0.115	CbGbCtD
Cilostazol—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0341	0.0697	CbGbCtD
Cilostazol—CYP3A4—Prednisone—systemic scleroderma	0.0273	0.0557	CbGbCtD
Cilostazol—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000369	0.000723	CcSEcCtD
Cilostazol—Dyspnoea—Leflunomide—systemic scleroderma	0.000369	0.000722	CcSEcCtD
Cilostazol—Hypotension—Mycophenolic acid—systemic scleroderma	0.000369	0.000722	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000369	0.000721	CcSEcCtD
Cilostazol—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000367	0.000719	CcSEcCtD
Cilostazol—Discomfort—Lisinopril—systemic scleroderma	0.000367	0.000718	CcSEcCtD
Cilostazol—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000367	0.000718	CcSEcCtD
Cilostazol—Dyspepsia—Leflunomide—systemic scleroderma	0.000364	0.000713	CcSEcCtD
Cilostazol—Vomiting—Mometasone—systemic scleroderma	0.000364	0.000712	CcSEcCtD
Cilostazol—Feeling abnormal—Azathioprine—systemic scleroderma	0.000361	0.000707	CcSEcCtD
Cilostazol—Rash—Mometasone—systemic scleroderma	0.000361	0.000706	CcSEcCtD
Cilostazol—Asthenia—Captopril—systemic scleroderma	0.00036	0.000705	CcSEcCtD
Cilostazol—Dermatitis—Mometasone—systemic scleroderma	0.00036	0.000705	CcSEcCtD
Cilostazol—Decreased appetite—Leflunomide—systemic scleroderma	0.00036	0.000704	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00036	0.000704	CcSEcCtD
Cilostazol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000358	0.000702	CcSEcCtD
Cilostazol—Headache—Mometasone—systemic scleroderma	0.000358	0.000701	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000357	0.0007	CcSEcCtD
Cilostazol—Insomnia—Mycophenolic acid—systemic scleroderma	0.000357	0.000699	CcSEcCtD
Cilostazol—Oedema—Lisinopril—systemic scleroderma	0.000356	0.000696	CcSEcCtD
Cilostazol—Pruritus—Captopril—systemic scleroderma	0.000355	0.000696	CcSEcCtD
Cilostazol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000355	0.000694	CcSEcCtD
Cilostazol—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000694	CcSEcCtD
Cilostazol—Pain—Leflunomide—systemic scleroderma	0.000354	0.000693	CcSEcCtD
Cilostazol—Infection—Lisinopril—systemic scleroderma	0.000353	0.000692	CcSEcCtD
Cilostazol—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000691	CcSEcCtD
Cilostazol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000352	0.000689	CcSEcCtD
Cilostazol—Shock—Lisinopril—systemic scleroderma	0.00035	0.000685	CcSEcCtD
Cilostazol—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000348	0.000682	CcSEcCtD
Cilostazol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000348	0.00068	CcSEcCtD
Cilostazol—Tachycardia—Lisinopril—systemic scleroderma	0.000347	0.00068	CcSEcCtD
Cilostazol—Abdominal pain—Azathioprine—systemic scleroderma	0.000347	0.000678	CcSEcCtD
Cilostazol—Body temperature increased—Azathioprine—systemic scleroderma	0.000347	0.000678	CcSEcCtD
Cilostazol—Skin disorder—Lisinopril—systemic scleroderma	0.000346	0.000676	CcSEcCtD
Cilostazol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000674	CcSEcCtD
Cilostazol—Diarrhoea—Captopril—systemic scleroderma	0.000344	0.000673	CcSEcCtD
Cilostazol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000343	0.000672	CcSEcCtD
Cilostazol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000672	CcSEcCtD
Cilostazol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00067	CcSEcCtD
Cilostazol—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000342	0.000669	CcSEcCtD
Cilostazol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000341	0.000668	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000341	0.000667	CcSEcCtD
Cilostazol—Nausea—Mometasone—systemic scleroderma	0.00034	0.000665	CcSEcCtD
Cilostazol—Anorexia—Lisinopril—systemic scleroderma	0.000339	0.000664	CcSEcCtD
Cilostazol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000339	0.000663	CcSEcCtD
Cilostazol—Pain—Mycophenolic acid—systemic scleroderma	0.000338	0.000661	CcSEcCtD
Cilostazol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000661	CcSEcCtD
Cilostazol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000336	0.000657	CcSEcCtD
Cilostazol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000652	CcSEcCtD
Cilostazol—Hypotension—Lisinopril—systemic scleroderma	0.000332	0.000651	CcSEcCtD
Cilostazol—Dizziness—Captopril—systemic scleroderma	0.000332	0.00065	CcSEcCtD
Cilostazol—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000332	0.000649	CcSEcCtD
Cilostazol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00033	0.000645	CcSEcCtD
Cilostazol—Urticaria—Leflunomide—systemic scleroderma	0.000329	0.000644	CcSEcCtD
Cilostazol—Body temperature increased—Leflunomide—systemic scleroderma	0.000327	0.000641	CcSEcCtD
Cilostazol—Abdominal pain—Leflunomide—systemic scleroderma	0.000327	0.000641	CcSEcCtD
Cilostazol—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000327	0.000639	CcSEcCtD
Cilostazol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000325	0.000637	CcSEcCtD
Cilostazol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000636	CcSEcCtD
Cilostazol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000636	CcSEcCtD
Cilostazol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000636	CcSEcCtD
Cilostazol—Myocardial infarction—Prednisone—systemic scleroderma	0.000325	0.000636	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000324	0.000634	CcSEcCtD
Cilostazol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000324	0.000634	CcSEcCtD
Cilostazol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000323	0.000632	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000323	0.000632	CcSEcCtD
Cilostazol—Insomnia—Lisinopril—systemic scleroderma	0.000322	0.00063	CcSEcCtD
Cilostazol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000321	0.000629	CcSEcCtD
Cilostazol—Paraesthesia—Lisinopril—systemic scleroderma	0.000319	0.000625	CcSEcCtD
Cilostazol—Vomiting—Captopril—systemic scleroderma	0.000319	0.000625	CcSEcCtD
Cilostazol—Dyspnoea—Lisinopril—systemic scleroderma	0.000317	0.000621	CcSEcCtD
Cilostazol—Rash—Captopril—systemic scleroderma	0.000317	0.00062	CcSEcCtD
Cilostazol—Dermatitis—Captopril—systemic scleroderma	0.000316	0.000619	CcSEcCtD
Cilostazol—Headache—Captopril—systemic scleroderma	0.000315	0.000616	CcSEcCtD
Cilostazol—Dyspepsia—Lisinopril—systemic scleroderma	0.000313	0.000613	CcSEcCtD
Cilostazol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000312	0.000611	CcSEcCtD
Cilostazol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000312	0.000611	CcSEcCtD
Cilostazol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000312	0.00061	CcSEcCtD
Cilostazol—Asthma—Methotrexate—systemic scleroderma	0.000311	0.000608	CcSEcCtD
Cilostazol—Infection—Mycophenolate mofetil—systemic scleroderma	0.00031	0.000606	CcSEcCtD
Cilostazol—Decreased appetite—Lisinopril—systemic scleroderma	0.000309	0.000605	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000307	0.000601	CcSEcCtD
Cilostazol—Shock—Mycophenolate mofetil—systemic scleroderma	0.000307	0.0006	CcSEcCtD
Cilostazol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000598	CcSEcCtD
Cilostazol—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000597	CcSEcCtD
Cilostazol—Pain—Lisinopril—systemic scleroderma	0.000304	0.000595	CcSEcCtD
Cilostazol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000595	CcSEcCtD
Cilostazol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000593	CcSEcCtD
Cilostazol—Diarrhoea—Azathioprine—systemic scleroderma	0.0003	0.000587	CcSEcCtD
Cilostazol—Haemoglobin—Prednisone—systemic scleroderma	0.000299	0.000585	CcSEcCtD
Cilostazol—Nausea—Captopril—systemic scleroderma	0.000298	0.000584	CcSEcCtD
Cilostazol—Haemorrhage—Prednisone—systemic scleroderma	0.000297	0.000582	CcSEcCtD
Cilostazol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000581	CcSEcCtD
Cilostazol—Asthenia—Leflunomide—systemic scleroderma	0.000297	0.000581	CcSEcCtD
Cilostazol—Pancytopenia—Methotrexate—systemic scleroderma	0.000295	0.000577	CcSEcCtD
Cilostazol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000293	0.000574	CcSEcCtD
Cilostazol—Pruritus—Leflunomide—systemic scleroderma	0.000293	0.000573	CcSEcCtD
Cilostazol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000291	0.00057	CcSEcCtD
Cilostazol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000291	0.000569	CcSEcCtD
Cilostazol—Dizziness—Azathioprine—systemic scleroderma	0.00029	0.000567	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000556	CcSEcCtD
Cilostazol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000283	0.000555	CcSEcCtD
Cilostazol—Diarrhoea—Leflunomide—systemic scleroderma	0.000283	0.000554	CcSEcCtD
Cilostazol—Urticaria—Lisinopril—systemic scleroderma	0.000283	0.000553	CcSEcCtD
Cilostazol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000282	0.000552	CcSEcCtD
Cilostazol—Abdominal pain—Lisinopril—systemic scleroderma	0.000281	0.00055	CcSEcCtD
Cilostazol—Body temperature increased—Lisinopril—systemic scleroderma	0.000281	0.00055	CcSEcCtD
Cilostazol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000548	CcSEcCtD
Cilostazol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000279	0.000547	CcSEcCtD
Cilostazol—Vomiting—Azathioprine—systemic scleroderma	0.000279	0.000546	CcSEcCtD
Cilostazol—Pneumonia—Methotrexate—systemic scleroderma	0.000278	0.000545	CcSEcCtD
Cilostazol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000544	CcSEcCtD
Cilostazol—Rash—Azathioprine—systemic scleroderma	0.000276	0.000541	CcSEcCtD
Cilostazol—Dermatitis—Azathioprine—systemic scleroderma	0.000276	0.00054	CcSEcCtD
Cilostazol—Headache—Azathioprine—systemic scleroderma	0.000275	0.000538	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000274	0.000537	CcSEcCtD
Cilostazol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000274	0.000537	CcSEcCtD
Cilostazol—Dizziness—Leflunomide—systemic scleroderma	0.000274	0.000536	CcSEcCtD
Cilostazol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000271	0.00053	CcSEcCtD
Cilostazol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00027	0.000529	CcSEcCtD
Cilostazol—Angiopathy—Prednisone—systemic scleroderma	0.00027	0.000528	CcSEcCtD
Cilostazol—Conjunctivitis—Methotrexate—systemic scleroderma	0.000269	0.000527	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000527	CcSEcCtD
Cilostazol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000522	CcSEcCtD
Cilostazol—Haematuria—Methotrexate—systemic scleroderma	0.000264	0.000517	CcSEcCtD
Cilostazol—Vomiting—Leflunomide—systemic scleroderma	0.000263	0.000515	CcSEcCtD
Cilostazol—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000262	0.000512	CcSEcCtD
Cilostazol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000261	0.000511	CcSEcCtD
Cilostazol—Epistaxis—Methotrexate—systemic scleroderma	0.000261	0.000511	CcSEcCtD
Cilostazol—Rash—Leflunomide—systemic scleroderma	0.000261	0.000511	CcSEcCtD
Cilostazol—Dermatitis—Leflunomide—systemic scleroderma	0.000261	0.00051	CcSEcCtD
Cilostazol—Nausea—Azathioprine—systemic scleroderma	0.00026	0.00051	CcSEcCtD
Cilostazol—Headache—Leflunomide—systemic scleroderma	0.000259	0.000508	CcSEcCtD
Cilostazol—Agranulocytosis—Methotrexate—systemic scleroderma	0.000258	0.000506	CcSEcCtD
Cilostazol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000503	CcSEcCtD
Cilostazol—Asthenia—Lisinopril—systemic scleroderma	0.000255	0.0005	CcSEcCtD
Cilostazol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000499	CcSEcCtD
Cilostazol—Pruritus—Lisinopril—systemic scleroderma	0.000252	0.000493	CcSEcCtD
Cilostazol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000251	0.000491	CcSEcCtD
Cilostazol—Haemoglobin—Methotrexate—systemic scleroderma	0.00025	0.000489	CcSEcCtD
Cilostazol—Rash—Mycophenolic acid—systemic scleroderma	0.000249	0.000487	CcSEcCtD
Cilostazol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000249	0.000487	CcSEcCtD
Cilostazol—Haemorrhage—Methotrexate—systemic scleroderma	0.000249	0.000486	CcSEcCtD
Cilostazol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000485	CcSEcCtD
Cilostazol—Headache—Mycophenolic acid—systemic scleroderma	0.000247	0.000484	CcSEcCtD
Cilostazol—Pharyngitis—Methotrexate—systemic scleroderma	0.000247	0.000483	CcSEcCtD
Cilostazol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000482	CcSEcCtD
Cilostazol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000482	CcSEcCtD
Cilostazol—Nausea—Leflunomide—systemic scleroderma	0.000246	0.000481	CcSEcCtD
Cilostazol—Diarrhoea—Lisinopril—systemic scleroderma	0.000243	0.000476	CcSEcCtD
Cilostazol—Ill-defined disorder—Prednisone—systemic scleroderma	0.00024	0.00047	CcSEcCtD
Cilostazol—Anaemia—Prednisone—systemic scleroderma	0.000239	0.000468	CcSEcCtD
Cilostazol—Dizziness—Lisinopril—systemic scleroderma	0.000235	0.00046	CcSEcCtD
Cilostazol—Erythema multiforme—Methotrexate—systemic scleroderma	0.000235	0.00046	CcSEcCtD
Cilostazol—Nausea—Mycophenolic acid—systemic scleroderma	0.000235	0.000459	CcSEcCtD
Cilostazol—Malaise—Prednisone—systemic scleroderma	0.000233	0.000457	CcSEcCtD
Cilostazol—Vertigo—Prednisone—systemic scleroderma	0.000233	0.000455	CcSEcCtD
Cilostazol—Syncope—Prednisone—systemic scleroderma	0.000232	0.000454	CcSEcCtD
Cilostazol—Tinnitus—Methotrexate—systemic scleroderma	0.000232	0.000454	CcSEcCtD
Cilostazol—Cardiac disorder—Methotrexate—systemic scleroderma	0.000231	0.000451	CcSEcCtD
Cilostazol—Loss of consciousness—Prednisone—systemic scleroderma	0.000228	0.000445	CcSEcCtD
Cilostazol—Vomiting—Lisinopril—systemic scleroderma	0.000226	0.000443	CcSEcCtD
Cilostazol—Angiopathy—Methotrexate—systemic scleroderma	0.000225	0.000441	CcSEcCtD
Cilostazol—Rash—Lisinopril—systemic scleroderma	0.000224	0.000439	CcSEcCtD
Cilostazol—Dermatitis—Lisinopril—systemic scleroderma	0.000224	0.000439	CcSEcCtD
Cilostazol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000224	0.000438	CcSEcCtD
Cilostazol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000438	CcSEcCtD
Cilostazol—Hypertension—Prednisone—systemic scleroderma	0.000224	0.000437	CcSEcCtD
Cilostazol—Chills—Methotrexate—systemic scleroderma	0.000223	0.000436	CcSEcCtD
Cilostazol—Headache—Lisinopril—systemic scleroderma	0.000223	0.000436	CcSEcCtD
Cilostazol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000432	CcSEcCtD
Cilostazol—Myalgia—Prednisone—systemic scleroderma	0.00022	0.000431	CcSEcCtD
Cilostazol—Arthralgia—Prednisone—systemic scleroderma	0.00022	0.000431	CcSEcCtD
Cilostazol—Anxiety—Prednisone—systemic scleroderma	0.00022	0.00043	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000219	0.000428	CcSEcCtD
Cilostazol—Discomfort—Prednisone—systemic scleroderma	0.000218	0.000426	CcSEcCtD
Cilostazol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000417	CcSEcCtD
Cilostazol—Nausea—Lisinopril—systemic scleroderma	0.000211	0.000414	CcSEcCtD
Cilostazol—Oedema—Prednisone—systemic scleroderma	0.000211	0.000414	CcSEcCtD
Cilostazol—Infection—Prednisone—systemic scleroderma	0.00021	0.000411	CcSEcCtD
Cilostazol—Back pain—Methotrexate—systemic scleroderma	0.000209	0.00041	CcSEcCtD
Cilostazol—Shock—Prednisone—systemic scleroderma	0.000208	0.000407	CcSEcCtD
Cilostazol—Nervous system disorder—Prednisone—systemic scleroderma	0.000207	0.000406	CcSEcCtD
Cilostazol—Tachycardia—Prednisone—systemic scleroderma	0.000206	0.000404	CcSEcCtD
Cilostazol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000206	0.000403	CcSEcCtD
Cilostazol—Skin disorder—Prednisone—systemic scleroderma	0.000205	0.000402	CcSEcCtD
Cilostazol—Anorexia—Prednisone—systemic scleroderma	0.000201	0.000394	CcSEcCtD
Cilostazol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000201	0.000393	CcSEcCtD
Cilostazol—Anaemia—Methotrexate—systemic scleroderma	0.0002	0.000391	CcSEcCtD
Cilostazol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000388	CcSEcCtD
Cilostazol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000385	CcSEcCtD
Cilostazol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000384	CcSEcCtD
Cilostazol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000382	CcSEcCtD
Cilostazol—Malaise—Methotrexate—systemic scleroderma	0.000195	0.000382	CcSEcCtD
Cilostazol—Vertigo—Methotrexate—systemic scleroderma	0.000194	0.00038	CcSEcCtD
Cilostazol—Leukopenia—Methotrexate—systemic scleroderma	0.000194	0.000379	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000192	0.000377	CcSEcCtD
Cilostazol—Insomnia—Prednisone—systemic scleroderma	0.000191	0.000374	CcSEcCtD
Cilostazol—Paraesthesia—Prednisone—systemic scleroderma	0.00019	0.000371	CcSEcCtD
Cilostazol—Cough—Methotrexate—systemic scleroderma	0.000189	0.000369	CcSEcCtD
Cilostazol—Dyspepsia—Prednisone—systemic scleroderma	0.000186	0.000364	CcSEcCtD
Cilostazol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000362	CcSEcCtD
Cilostazol—Myalgia—Methotrexate—systemic scleroderma	0.000184	0.00036	CcSEcCtD
Cilostazol—Chest pain—Methotrexate—systemic scleroderma	0.000184	0.00036	CcSEcCtD
Cilostazol—Arthralgia—Methotrexate—systemic scleroderma	0.000184	0.00036	CcSEcCtD
Cilostazol—Decreased appetite—Prednisone—systemic scleroderma	0.000184	0.000359	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000183	0.000358	CcSEcCtD
Cilostazol—Discomfort—Methotrexate—systemic scleroderma	0.000182	0.000356	CcSEcCtD
Cilostazol—Infection—Methotrexate—systemic scleroderma	0.000175	0.000343	CcSEcCtD
Cilostazol—Feeling abnormal—Prednisone—systemic scleroderma	0.000174	0.000341	CcSEcCtD
Cilostazol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000173	0.000339	CcSEcCtD
Cilostazol—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000173	0.000338	CcSEcCtD
Cilostazol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000173	0.000338	CcSEcCtD
Cilostazol—Skin disorder—Methotrexate—systemic scleroderma	0.000172	0.000336	CcSEcCtD
Cilostazol—Anorexia—Methotrexate—systemic scleroderma	0.000168	0.000329	CcSEcCtD
Cilostazol—Urticaria—Prednisone—systemic scleroderma	0.000168	0.000328	CcSEcCtD
Cilostazol—Body temperature increased—Prednisone—systemic scleroderma	0.000167	0.000327	CcSEcCtD
Cilostazol—Abdominal pain—Prednisone—systemic scleroderma	0.000167	0.000327	CcSEcCtD
Cilostazol—Hypotension—Methotrexate—systemic scleroderma	0.000165	0.000323	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000161	0.000315	CcSEcCtD
Cilostazol—Insomnia—Methotrexate—systemic scleroderma	0.00016	0.000313	CcSEcCtD
Cilostazol—Paraesthesia—Methotrexate—systemic scleroderma	0.000159	0.00031	CcSEcCtD
Cilostazol—Dyspnoea—Methotrexate—systemic scleroderma	0.000157	0.000308	CcSEcCtD
Cilostazol—Dyspepsia—Methotrexate—systemic scleroderma	0.000155	0.000304	CcSEcCtD
Cilostazol—Decreased appetite—Methotrexate—systemic scleroderma	0.000153	0.0003	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000152	0.000298	CcSEcCtD
Cilostazol—Asthenia—Prednisone—systemic scleroderma	0.000152	0.000297	CcSEcCtD
Cilostazol—Pain—Methotrexate—systemic scleroderma	0.000151	0.000296	CcSEcCtD
Cilostazol—Pruritus—Prednisone—systemic scleroderma	0.000149	0.000293	CcSEcCtD
Cilostazol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000146	0.000285	CcSEcCtD
Cilostazol—Diarrhoea—Prednisone—systemic scleroderma	0.000145	0.000283	CcSEcCtD
Cilostazol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000144	0.000283	CcSEcCtD
Cilostazol—Urticaria—Methotrexate—systemic scleroderma	0.00014	0.000275	CcSEcCtD
Cilostazol—Dizziness—Prednisone—systemic scleroderma	0.00014	0.000273	CcSEcCtD
Cilostazol—Abdominal pain—Methotrexate—systemic scleroderma	0.00014	0.000273	CcSEcCtD
Cilostazol—Body temperature increased—Methotrexate—systemic scleroderma	0.00014	0.000273	CcSEcCtD
Cilostazol—Vomiting—Prednisone—systemic scleroderma	0.000134	0.000263	CcSEcCtD
Cilostazol—Rash—Prednisone—systemic scleroderma	0.000133	0.000261	CcSEcCtD
Cilostazol—Dermatitis—Prednisone—systemic scleroderma	0.000133	0.00026	CcSEcCtD
Cilostazol—Headache—Prednisone—systemic scleroderma	0.000132	0.000259	CcSEcCtD
Cilostazol—Asthenia—Methotrexate—systemic scleroderma	0.000127	0.000248	CcSEcCtD
Cilostazol—Nausea—Prednisone—systemic scleroderma	0.000125	0.000246	CcSEcCtD
Cilostazol—Pruritus—Methotrexate—systemic scleroderma	0.000125	0.000244	CcSEcCtD
Cilostazol—Diarrhoea—Methotrexate—systemic scleroderma	0.000121	0.000236	CcSEcCtD
Cilostazol—Dizziness—Methotrexate—systemic scleroderma	0.000117	0.000229	CcSEcCtD
Cilostazol—Vomiting—Methotrexate—systemic scleroderma	0.000112	0.00022	CcSEcCtD
Cilostazol—Rash—Methotrexate—systemic scleroderma	0.000111	0.000218	CcSEcCtD
Cilostazol—Dermatitis—Methotrexate—systemic scleroderma	0.000111	0.000218	CcSEcCtD
Cilostazol—Headache—Methotrexate—systemic scleroderma	0.000111	0.000216	CcSEcCtD
Cilostazol—Nausea—Methotrexate—systemic scleroderma	0.000105	0.000205	CcSEcCtD
